FDA
-
-
-
-
-
-
-
MeiraGTx Announces the Presentation of Four Posters at the American Society of Gene and Cell Therapy (ASGCT) 2025 Annual Meeting
-
-
-
-
-
-
-
MeiraGTx Enters into a Strategic Collaboration with Hologen AI to Expedite Phase 3 Development of AAV-GAD for Parkinson’s Disease and Industrialize MeiraGTx’s Proprietary Manufacturing Process
-
-
-
-
-
-
-
MeiraGTx Announces Third Quarter 2024 Financial and Operational Results and Recent Business Updates
-
-
-
-
-
-
-
MeiraGTx Reports First Quarter 2024 Financial and Operational Results
-
-
-
-
-
-
-
MeiraGTx Announces Third Quarter 2023 Financial and Operational Results
-
-
-
-
-
-
-
MeiraGTx Announces its Wholly-Owned Gene Therapy Manufacturing Facility in Shannon, Ireland has Received Commercial MIA Authorization for QC Testing
-
-
-
-
-
-
-
MeiraGTx Announces $60 Million Private Placement of Ordinary Shares
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

